Ten-year Risk of Atherosclerotic Cardiovascular Disease Predicts Long-Term Mortality in Lipid-Lowering Therapy

被引：0
|
作者：
Ma, Zhiyuan
Moran, Lynn N.
Shirani, Jamshid
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Cholesterol-lowering drugs; Mortality; Risk Factors; Cardiovascular disease prevention;
D O I：
10.1161/circ.148.suppl_1.11813
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A11813
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Lipid-lowering treatment among older patients with atherosclerotic cardiovascular disease
    Nanna, Michael G.
    Nelson, Adam J.
    Haynes, Kevin
    Shambhu, Sonali
    Eapen, Zubin
    Cziraky, Mark J.
    Calvert, Sara B.
    Pagidipati, Neha J.
    Granger, Christopher B.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 (04) : 1243 - 1249
  • [2] Individualized lipid-lowering therapy to further reduce residual cardiovascular risk
    Weingaertner, Oliver
    Luetjohann, Dieter
    Ploesch, Torsten
    Elsaesser, Albrecht
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 169 : 198 - 201
  • [3] Contemporary use of lipid-lowering therapy for secondary prevention in Korean patients with atherosclerotic cardiovascular diseases
    Choi, Su-Yeon
    Yang, Bo Ram
    Kang, Hyun-Jae
    Park, Kyong Soo
    Kim, Hyo-Soo
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (03) : 593 - +
  • [4] Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy
    Galema-Boers, Annette M.
    Lenzen, Mattie J.
    Engelkes, Sophie R.
    Sijbrands, Eric J.
    van Lennep, Jeanine E. Roeters
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (02) : 409 - 416
  • [5] Absolute cardiovascular disease risk and lipid-lowering therapy among Aboriginal and Torres Strait Islander Australians
    Calabria, Bianca
    Korda, Rosemary J.
    Lovett, Raymond W.
    Fernando, Peter
    Martin, Tanya
    Malamoo, Leone
    Welsh, Jennifer
    Banks, Emily
    MEDICAL JOURNAL OF AUSTRALIA, 2018, 209 (01) : 35 - 41
  • [6] Ten-year atherosclerotic cardiovascular disease risk score in post-menopausal women with low bone mineral density
    Wani, Kaiser
    Sabico, Shaun
    Veronese, Nicola
    Al-Masri, Abeer A.
    Al-Daghri, Nasser M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2025, 37 (01)
  • [7] 2022: the year in cardiovascular disease - the year of upfront lipid lowering combination therapy
    Banach, Maciej
    Reiner, Zeljko
    Cicero, Arrigo F. G.
    Sabouret, Pierre
    Viigimaa, Margus
    Sahebkar, Amirhossein
    Postadzhiyan, Arman
    Gaita, Dan
    Pella, Daniel
    Penson, Peter E.
    ARCHIVES OF MEDICAL SCIENCE, 2022, 18 (06) : 1429 - 1434
  • [8] Residual cardiovascular disease risk in heart failure patients. What is the real role of lipid-lowering therapy?
    Chrysohoou, Christina
    Tsioufis, Kostas P.
    ARCHIVES OF MEDICAL SCIENCE, 2024, 20 (04) : 1358 - 1362
  • [9] The Relationship of Ten-Year Cardiovascular Disease Risk and Clinical Features in Patients with Schizophrenia
    Kapici, Yasar
    Guc, Bulut
    Tekin, Atilla
    Abus, Sabri
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2023, 60 (03): : 231 - 235
  • [10] Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project
    Conroy, RM
    Pyörälä, K
    Fitzgerald, AP
    Sans, S
    Menotti, A
    De Backer, G
    De Bacquer, D
    Ducimetière, P
    Jousilahti, P
    Keil, U
    Njolstad, I
    Oganov, RG
    Thomsen, T
    Tunstall-Pedoe, H
    Tverdal, A
    Wedel, H
    Whincup, P
    Wilhelmsen, L
    Graham, IM
    EUROPEAN HEART JOURNAL, 2003, 24 (11) : 987 - 1003
12345